Biomérieux third-quarter sales grew more than expected 

By Reuters News

- French biotechnology firm Biomérieux BIOX.PA reported on Tuesday a better-than-expected organic sales growth in the third quarter, helped by a 13% increase in sales from GO 28 growth drivers.

Total sales for the period came in at €1,042 million ($1.17 billion), up 8% year on year, above the company's compiled median consensus for sales of €1,007 billion and organic growth of 5.9%.

($1 = 0.8937 euros)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk